We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$485M
AUM Growth
+$29.1M
Cap. Flow
-$15.4M
Cap. Flow %
-3.18%
Top 10 Hldgs %
51.57%
Holding
81
New
1
Increased
35
Reduced
19
Closed
10

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$20.7M
2
AMBP icon
Ardagh Metal Packaging
AMBP
+$4.55M
3
SAFE
Safehold
SAFE
+$4.08M
4
FLWS icon
1-800-Flowers.com
FLWS
+$3.62M
5
DXLG icon
Destination XL Group
DXLG
+$3.4M

Top Sells

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$14.9M
2
TBPH icon
Theravance Biopharma
TBPH
+$11M
3
AVTA
Avantax, Inc. Common Stock
AVTA
+$6.33M
4
VRTS icon
Virtus Investment Partners
VRTS
+$5.09M
5
PCG icon
PG&E
PCG
+$4.25M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.15%
2 Healthcare 21.39%
3 Financials 12.53%
4 Real Estate 9.47%
5 Communication Services 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIX icon
51
Comp X International
CIX
$349M
$1.03M 0.21%
55,475
-37,685
-40% -$701K
ADVM
52
DELISTED
Adverum Biotechnologies
ADVM
$947K 0.2%
163,500
+73,500
+82% +$557K
AMR icon
53
Alpha Metallurgical Resources
AMR
$1.74B
$925K 0.19%
6,319
– –
CTMX icon
54
CytomX Therapeutics
CTMX
$675M
$912K 0.19%
570,000
-230,000
-29% -$340K
OLMA icon
55
Olema Pharmaceuticals
OLMA
$1B
$882K 0.18%
360,000
-40,000
-10% -$117K
ORIC icon
56
Oric Pharmaceuticals
ORIC
$1.15B
$854K 0.18%
145,000
+20,000
+16% +$67.5K
ALR
57
DELISTED
AlerisLife Inc
ALR
$825K 0.17%
1,500,000
– –
IOVA icon
58
Iovance Biotherapeutics
IOVA
$1.82B
$767K 0.16%
120,000
+15,000
+14% +$117K
BDTX icon
59
Black Diamond Therapeutics
BDTX
$96.8M
$567K 0.12%
315,000
-35,000
-10% -$63K
DBTX
60
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$554K 0.11%
270,000
-30,000
-10% -$91.4K
FBRX icon
61
Forte Biosciences
FBRX
$1.57B
$549K 0.11%
21,950
+1,950
+10% +$50K
WGS icon
62
GeneDx Holdings
WGS
$1.93B
$528K 0.11%
60,606
+33,333
+122% +$734K
NUVB icon
63
Nuvation Bio
NUVB
$2.2B
$461K 0.1%
240,000
+30,000
+14% +$60.7K
TCRX icon
64
TScan Therapeutics
TCRX
$48.6M
$375K 0.08%
230,000
+30,000
+15% +$73.6K
IOBT
65
DELISTED
IO Biotech
IOBT
$207K 0.04%
90,000
-10,000
-10% -$26.5K
BRLIR
66
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$86.9K 0.02%
457,409
– –
EUDA icon
67
EUDA Health Holdings
EUDA
$57.8M
$33.4K 0.01%
+1,000
New +$117K
VHAQ.RT
68
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$32.6K 0.01%
250,000
– –
LFLYW
69
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$25.4K 0.01%
634,640
– –
ARIZR
70
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$22.5K ﹤0.01%
250,000
– –
ILPT
71
Industrial Logistics Properties Trust
ILPT
$575M
– –
-500,000
Closed -$2.75M
QURE icon
72
uniQure
QURE
$3.03B
– –
-175,000
Closed -$3.28M
SLVM icon
73
Sylvamo
SLVM
$1.49B
– –
-438,674
Closed -$14.9M
VRTS icon
74
Virtus Investment Partners
VRTS
$1.06B
– –
-31,916
Closed -$5.09M
LFLY
75
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
– –
-1,750
Closed -$24K
1 2
3
4

Similar funds

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
FPI
Financial Plan Inc Bellingham, Washington $933M AUM

Newtyn Management's Q4 2022 Portfolio in Review

As of Q4 2022, Newtyn Management held 81 positions worth $485M, up 6.4% from $455M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Newtyn Management withdrew a net $15.4M in Q4 2022, closing 10 positions and reducing 19 holdings. Its most notable exit was Sylvamo, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Newtyn Management opened a new position in EUDA Health Holdings worth $33.4K.

  • Newtyn Management's largest Q4 2022 buy was EUDA Health Holdings: 1,000 shares worth $33.4K.
  • Newtyn Management added most to People Inc in Q4 2022, an estimated $20.7M increase.
  • Newtyn Management's biggest Q4 2022 reduction was Theravance Biopharma, cutting an estimated $11M.
  • Newtyn Management fully exited Sylvamo in Q4 2022, selling an estimated $14.9M.
  • Newtyn Management's ten largest holdings make up 52% of its $485M portfolio in Q4 2022.
  • Newtyn Management opened 1 new position and closed 10 in Q4 2022.
  • Newtyn Management's portfolio value rose 6.4% quarter-over-quarter to $485M.

Based on Newtyn Management's 13F filing for Q4 2022, filed 14 Feb 2023.